We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Pfizer Inc | NYSE:PFE | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.19 | 0.75% | 25.45 | 25.54 | 25.20 | 25.33 | 46,479,621 | 00:58:17 |
From Apr 2019 to Apr 2024
By Cecilia Butini
BioNTech SE and Pfizer Inc. said Monday that they will supply the European Union with an additional 100 million doses of their coronavirus vaccine in 2021, after the European Commission opted to purchase those doses as part of a previously signed agreement.
The companies said that this purchase brings the total number of doses to be delivered to the EU to 600 million.
The European Commission had signed an expanded advanced purchase agreement in February, which included the possible purchase of additional 100 million doses.
Pfizer's chief executive Albert Bourla said in a statement that the companies plan to deliver 250 million doses to the EU in the second quarter.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
April 19, 2021 04:36 ET (08:36 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Pfizer Chart |
1 Month Pfizer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
